Off-topic for aiqbench
This story was gathered from a source we follow but falls outside AI and quantum coverage, so there is no aiqbench take for it.
EGFR-targeted antibody−toxin conjugate in recurrent glioma: a phase 1 trial
Nature1 min read
EGFR-targeted antibody−toxin conjugate in recurrent glioma: a phase 1 trial Nature
Read the full article at NatureRelated coverage
AI & Society
How to build a cancer vaccine, and whether they will work this time
LessWrong · Jun 8, 2026
AI Products
XtalPi Holdings Limited: XtalPi Holdings Announces 2026 Interim Results
finanznachrichten.de · Aug 19, 2026
Quantum Comms
Limits of independent and identical measurements for quantum illumination with an unknown return phase
arXiv · Aug 17, 2026
Machine Learning
SchemaMem: Schema-Indexed Recurrent Memory for Delayed State Retrieval
arXiv · Sep 30, 2026